Terms: = Lymphoma AND ATR, Q13535, 545, ENSG00000175054, MEC1, SCKL, SCKL1, FRP1 AND Prognosis
19 results:
1. Selectively targeting BCL6 using a small molecule inhibitor is a potential therapeutic strategy for ovarian cancer.
Wu M; Xie J; Xing Y; Zhang L; Chen H; Tang B; Zhou M; Lv S; Huang D; Jian S; Zhou C; Liu M; Guo W; Chen Y; Yi Z
Int J Biol Sci; 2024; 20(2):486-501. PubMed ID: 38169532
[TBL] [Abstract] [Full Text] [Related]
2. CDC6, a key replication licensing factor, is overexpressed and confers poor prognosis in diffuse large B-cell lymphoma.
Shen M; Zhang Y; Tang L; Fu Q; Zhang J; Xu Y; Zeng H; Li Y
BMC Cancer; 2023 Oct; 23(1):978. PubMed ID: 37833632
[TBL] [Abstract] [Full Text] [Related]
3. TuBG1 promotes hepatocellular carcinoma via atr/P53-apoptosis and cycling pathways.
Zhang Y; Wang ZZ; Han AQ; Yang MY; Zhu LX; Pan FM; Wang Y
Hepatobiliary Pancreat Dis Int; 2024 Apr; 23(2):195-209. PubMed ID: 37806848
[TBL] [Abstract] [Full Text] [Related]
4. Identification and validation of hub genes in CD5-positive diffuse large B-cell lymphoma.
Yang M; Niu X; Yang X; Sun Y; Su W; Zhang J; Wu Q; Wang Y; Zhang Q; Ji H
Exp Biol Med (Maywood); 2023 Sep; 248(17):1469-1478. PubMed ID: 36847415
[TBL] [Abstract] [Full Text] [Related]
5. Analysis of the Clinicopathologic Characteristics and prognosis of Head and Neck lymphoma.
Yan S; Ma J; Yang M; Liu B; Li S; Yang L; Zhang Q; Li X
Anal Cell Pathol (Amst); 2022; 2022():4936099. PubMed ID: 35242496
[TBL] [Abstract] [Full Text] [Related]
6. [Characteristics of primary cutaneous rare nasal extranodal NK/T cell lymphoma: a clinicopathological study of 15 cases].
Zhao WG; Zhao HY; Wang GN; Zhang DD; Zhang YP; Zhao HB; Zhang CL; Zhang M; Li WC
Zhonghua Bing Li Xue Za Zhi; 2021 Jun; 50(6):609-614. PubMed ID: 34078048
[No Abstract] [Full Text] [Related]
7. Molecular pathogenic pathways in extranodal NK/T cell lymphoma.
de Mel S; Hue SS; Jeyasekharan AD; Chng WJ; Ng SB
J Hematol Oncol; 2019 Apr; 12(1):33. PubMed ID: 30935402
[TBL] [Abstract] [Full Text] [Related]
8. The correlation of clinicopathological features and prognosis in extranodal natural killer/T cell lymphoma: a report of 42 cases in the early stage.
Zeng L; Huang W; Cao Z; Zheng B; Liu X; Guo L; Feng X
Ann Hematol; 2019 Jun; 98(6):1467-1476. PubMed ID: 30895352
[TBL] [Abstract] [Full Text] [Related]
9. Prognostic significance of monocyte chemoattractant protein-1 and CC chemokine receptor 2 in diffuse large B cell lymphoma.
Li YL; Shi ZH; Wang X; Gu KS; Zhai ZM
Ann Hematol; 2019 Feb; 98(2):413-422. PubMed ID: 30374624
[TBL] [Abstract] [Full Text] [Related]
10. Inhibition of MEK and atr is effective in a B-cell acute lymphoblastic leukemia model driven by
Chu SH; Song EJ; Chabon JR; Minehart J; Matovina CN; Makofske JL; Frank ES; Ross K; Koche RP; Feng Z; Xu H; Krivtsov A; Nussenzweig A; Armstrong SA
Blood Adv; 2018 Oct; 2(19):2478-2490. PubMed ID: 30266823
[TBL] [Abstract] [Full Text] [Related]
11. The expression of inhibitor of bruton's tyrosine kinase gene is progressively up regulated in the clinical course of chronic lymphocytic leukaemia conferring resistance to apoptosis.
Albano F; Chiurazzi F; Mimmi S; Vecchio E; Pastore A; Cimmino C; Frieri C; Iaccino E; Pisano A; Golino G; Fiume G; Mallardo M; Scala G; Quinto I
Cell Death Dis; 2018 Jan; 9(1):13. PubMed ID: 29317636
[TBL] [Abstract] [Full Text] [Related]
12. Prognostic significance of copy number alterations in adolescent and adult patients with precursor B acute lymphoblastic leukemia enrolled in PETHEMA protocols.
Ribera J; Morgades M; Zamora L; Montesinos P; Gómez-Seguí I; Pratcorona M; Sarrà J; Guàrdia R; Nomdedeu J; Tormo M; Martínez-Lopez J; Hernández-Rivas JM; González-Campos J; Barba P; Escoda L; Genescà E; Solé F; Millá F; Feliu E; Ribera JM;
Cancer; 2015 Nov; 121(21):3809-17. PubMed ID: 26194343
[TBL] [Abstract] [Full Text] [Related]
13. MYC regulates the core pre-mRNA splicing machinery as an essential step in lymphomagenesis.
Koh CM; Bezzi M; Low DH; Ang WX; Teo SX; Gay FP; Al-Haddawi M; Tan SY; Osato M; Sabò A; Amati B; Wee KB; Guccione E
Nature; 2015 Jul; 523(7558):96-100. PubMed ID: 25970242
[TBL] [Abstract] [Full Text] [Related]
14. [Correlation analysis of FPGS rs10760502G>a polymorphism with prognosis and MTX-related toxicity in pediatric B-cell acute lymphoblastic leukemia].
Liu SG; Gao C; Li ZG; Li WJ; Cui L; Zhao XX; Zheng HY; Wu MY; Zhang RD
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Apr; 22(2):291-7. PubMed ID: 24762994
[TBL] [Abstract] [Full Text] [Related]
15. Low lymphocyte-to-monocyte ratio predicts unfavorable prognosis in non-germinal center type diffuse large B-cell lymphoma.
Wei X; Huang F; Wei Y; Jing H; Xie M; Hao X; Feng R
Leuk Res; 2014 Jun; 38(6):694-8. PubMed ID: 24713260
[TBL] [Abstract] [Full Text] [Related]
16. Chk2 deficiency in Myc overexpressing lymphoma cells elicits a synergistic lethal response in combination with PARP inhibition.
Höglund A; Strömvall K; Li Y; Forshell LP; Nilsson JA
Cell Cycle; 2011 Oct; 10(20):3598-607. PubMed ID: 22030621
[TBL] [Abstract] [Full Text] [Related]
17. Alterations in atr in nasal NK/T-cell lymphoma and chronic active Epstein-Barr virus infection.
Liu A; Takakuwa T; Luo WJ; Fujita S; Aozasa K
Cancer Sci; 2006 Jul; 97(7):605-10. PubMed ID: 16827800
[TBL] [Abstract] [Full Text] [Related]
18. Serum level of soluble CD30 correlates with the aggressiveness of adult T-cell leukemia/lymphoma.
Nishioka C; Takemoto S; Kataoka S; Yamanaka S; Moriki T; Shoda M; Watanabe T; Taguchi H
Cancer Sci; 2005 Nov; 96(11):810-5. PubMed ID: 16271075
[TBL] [Abstract] [Full Text] [Related]
19. Results of a uniform histopathologic review system of lymphoma cases. A ten-year study from the Southeastern Cancer Study Group.
Vélez-García E; Durant J; Gams R; Bartolucci A
Cancer; 1983 Aug; 52(4):675-9. PubMed ID: 6861104
[TBL] [Abstract] [Full Text] [Related]